• Go to:

For the EAU Virtual Congress in July 2021, we asked patients and patient advocates around the world to present their research and to give their perspective on how to improve patient-physician communications, and address presumptions and change perceptions on both sides. Click here to watch the EAU21 Patient Poster Session.

We thank all who submitted their abstract for their enormous effort and their willingness to share their story, which helped us to identify unmet needs that are not or insufficiently addressed by the disease-orientated physician.

Abstracts selected for presentation

The EAU22 Patient Poster Session takes place on Monday, 4 July from 07.45 until 08.45. Location:  Grey Area, room Emerald.

For this year, patients and patient advocates’ submissions range from solutions, novel approaches and best practices revolving around physical and psychological well-being, finance and work, patient involvement in clinical research, development of care pathways and clinical guidelines, and patient engagement/advocacy in healthcare policy.

Out of all the submissions, a total of six abstracts were selected to be presented in the Patient Poster Session.

Click here to see which abstracts have been selected for presentation

Click here to view an abstract

Abstracts selected for publication in i-Kiosk

A total of 6 abstracts were selected to be included on the EAU22 virtual platform and in the i-Kiosk stand which is located at the Patient Lounge Booth D60, exhibition floor.

[AP22-0004]
Waiting & Consultation Time in Urology OPD
First author: H. Mumtaz, Islamabad (PK)
Email: hassanmumtaz.dr@gmail.com

[AP22-0013]
Plain-language summaries (PLSs): evolving tools to make medical research accessible and
understandable for people affected by cancer
First author: J.T.N. Nowak, Brooklyn (USA)

[AP22-0019]
Patient’s experience helping the patient experience. A review of Neobladder and Ilea Conduit Post Op Surveys
First author: G. Ptasznik, Melbourne (AU)
Email: gptasz@gmail.com

[AP22-0021]
Patients being patient with other patients. How Bladder cancer survivors are using chatbots and direct messaging to support newly diagnosed patients
First author: G. Ptasznik, Melbourne (AU)
Email: gptasz@gmail.com

[AP22-0023]
Why patients leave clinical trials: the kidney cancer patient perspective
First author: J.E. Bjorkqvist, Duivendrecht (NL)
Email: josefine@ikcc.org

[AP-0026]
The impact of COVID-19 on the kidney cancer community
First author: R. Giles, Duivendrecht (NL)
Email: rachelhelengiles@gmail.com

We hope to see you in Amsterdam!

error: Content is protected !!